Keratin 17 expression as a marker for epithelial transformation in viral warts
- PMID: 7504888
- PMCID: PMC1887274
Keratin 17 expression as a marker for epithelial transformation in viral warts
Abstract
The profile of keratin expression in benign warts from various cutaneous and mucosal sites along with dysplastic warts and squamous cell carcinomas has been examined using a panel of monospecific antibodies to epithelial keratins. Viral warts and verrucous keratoses from immunosuppressed renal transplant recipients show a spectrum of squamous atypia from benign lesions, from minimal changes to full thickness dysplasia. Changes associated with malignancy include loss of differentiation-specific keratins 1 and 10 together with expansion of basal cell epitopes and inappropriate expression of simple epithelial keratins 8, 18, and 19 in advanced squamous cell carcinoma. This late expression of keratins 8 and 18 contrasts with early expression of keratin 17 in all dysplastic lesions examined. Keratin 17 is found suprabasally in hyperproliferative lesions, including benign warts, but marked basal plus suprabasal expression is seen increasingly in malignantly transformed epidermis. These findings were not specific to immunosuppression, as shown by identical findings in control squamous cell carcinoma from nonimmunosuppressed individuals. Keratin 17 expression may prove prognostically helpful when assessing dysplasia in epidermal tumors.
Similar articles
-
Monoclonal antibodies specific for subsets of epidermal keratins: biochemical and immunocytochemical characterization--applications in pathology and cell culture.J Pathol. 1985 Apr;145(4):341-54. doi: 10.1002/path.1711450407. J Pathol. 1985. PMID: 2582105
-
PCNA expression in cutaneous keratinous neoplasms and verruca vulgaris.Am J Pathol. 1992 Jul;141(1):139-42. Am J Pathol. 1992. PMID: 1352943 Free PMC article.
-
Changes in keratin expression during malignant progression of transformed mouse epidermal keratinocytes.Exp Cell Res. 1993 Jan;204(1):11-21. doi: 10.1006/excr.1993.1003. Exp Cell Res. 1993. PMID: 7677983
-
Disorders of keratinisation.Practitioner. 2007 Sep;251(1698):60-5. Practitioner. 2007. PMID: 17955881 Review. No abstract available.
-
Expression of keratins in cutaneous epithelial tumors and related disorders--distribution and clinical significance.Exp Dermatol. 2011 Mar;20(3):217-28. doi: 10.1111/j.1600-0625.2009.01006.x. Exp Dermatol. 2011. PMID: 21323743 Review.
Cited by
-
Effect of Baicalin on Wound Healing in a Mouse Model of Pressure Ulcers.Int J Mol Sci. 2022 Dec 25;24(1):329. doi: 10.3390/ijms24010329. Int J Mol Sci. 2022. PMID: 36613772 Free PMC article.
-
Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study.Int J Dent. 2021 Nov 22;2021:4089549. doi: 10.1155/2021/4089549. eCollection 2021. Int J Dent. 2021. PMID: 34853592 Free PMC article.
-
Abnormal keratin expression pattern in prurigo nodularis epidermis.Skin Health Dis. 2021 Dec 1;2(1):e75. doi: 10.1002/ski2.75. eCollection 2022 Mar. Skin Health Dis. 2021. PMID: 35665210 Free PMC article.
-
Characterization of keratin and cell cycle protein expression in cell lines from squamous intraepithelial lesions progressing towards a malignant phenotype.Br J Cancer. 1998 Mar;77(5):766-75. doi: 10.1038/bjc.1998.125. Br J Cancer. 1998. PMID: 9514056 Free PMC article.
-
Immunolocalization of vimentin, keratin 17, Ki-67, involucrin, β-catenin and E-cadherin in cutaneous squamous cell carcinoma.Pathol Oncol Res. 2014 Apr;20(2):263-6. doi: 10.1007/s12253-013-9690-5. Epub 2013 Sep 4. Pathol Oncol Res. 2014. PMID: 23999979
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical